Analysis of the stability of alanine aminotransferase (ALT) levels in donor samples

1.Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 1981;304:989–94.10.1056/NEJM198104233041701Search in Google Scholar

2.Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE. Donor transaminase and recipient hepatitis: impact on blood transfusion services. JAMA 1981;246:630–4.10.1001/jama.1981.03320060032017Search in Google Scholar

3.Alter HJ, Hoofnagle JH. Non-A, non-B: observations on the first decade. In: Vyas GN, DienstagJL, Hoofnagle JH, eds. Viral hepatitis and liver disease. Orlando, FL: Grune and Stratton, 1984:345–54.Search in Google Scholar

4.International Forum. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of posttransfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter? Vox Sang 1983;44:48–64.10.1111/j.1423-0410.1983.tb04103.xSearch in Google Scholar

5.Kahn RA. Reducing hepatitis by testing blood for alanine aminotransferase (letter). N Engl J Med 1983;308:844–5.10.1056/NEJM198304073081417Search in Google Scholar

6.Cuccherini B, Nussbaum SJ, Seeff LB, Lucas L. Zimmerman HJ. Stability of aspartate aminotransferase and alanine aminotransferase activities. J Lab Clin Med 1983;102:370–6.Search in Google Scholar

7.Williams KM, Williams AE, Kline LM, Dodd RY. Stability of serum alanine aminotransferase activity. Transfusion 1987;27:431–3.10.1046/j.1537-2995.1987.27587320539.xSearch in Google Scholar

1.Abraham CV, Bakerman S. Isolation and purification of the Rho(D) blood group receptor component from human erythrocyte membrane. Clin Chim Acta 1975;60:33–43.10.1016/0009-8981(75)90177-1Search in Google Scholar

2.Anstee DJ. Blood group MNSs-active sialoglycoproteins of the human erythrocyte membrane. In: Sandler SG, Nusbacher J, Schanfield MS, eds. Immunobiology of the erythrocyte. New York: Alan R Liss, 1980:67–98.Search in Google Scholar

3.Anstee DJ. The blood group MNSs-active sialoglycoproteins. Semin Hematol 1981;18:13–31.Search in Google Scholar

4.Anstee DJ, Mawby WJ, Parsons SF, Tanner MJA, Giles CM. A novel hybrid sialoglycoprotein in St^a positive human erythrocytes. J Immunogenet 1982;9:51–5.10.1111/j.1744-313X.1982.tb00782.xSearch in Google Scholar

5.Anstee DJ, Mawby WJ, Tanner MJA. Abnormal blood group Ss-active sialogylcoproteins in the membrane of Miltenberger class III, IV and V human erythrocytes. BiochemJ 1979;l83:193-203.10.1042/bj1830193Search in Google Scholar

6.Anstee DJ, Ridgwell K, Tanner MJA, Daniels GL, Parsons SF. Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins β and γ. Biochem J 1984;221:97–105.10.1042/bj2210097Search in Google Scholar

7.Baranowski T, Lisowska E, Morawiecki A, Romanowska E, Strozecka K. Studies on blood group antigens M and N. III. Chemical composition of purified antigens. Arch Immunol i Terapii Dosw 1959;7:15–27.Search in Google Scholar

8.Basu MK, Flamm M, Schachter D, Bertles JF, Maniatis A. Effects of modulating erythrocyte membrane cholesterol on Rho(D) antigen expression. Biochem Biophys Res Comm 1980;95;87–93.10.1016/0006-291X(80)90870-0Search in Google Scholar

9.Blanchard D, Capon C, Leroy Y, Cartron JP, Fournet B. Comparative study of glycophorin A derived O-glycans from human Cad, Sd(a+) and Sd(a−) erythrocytes. Biochem J 1985;232:813–8.10.1042/bj2320813Search in Google Scholar

10.Blanchard D, Cartron JP, Fournet B, Montreuil J, van Halbeek H, Vliegenthart JFG. Primary structure of the oligosaccharide determinant of blood group Cad specificity. J Biol Chem 1983; 258:7691–510.1016/S0021-9258(18)32234-8Search in Google Scholar

11.Blanchard D, Dahr W, Cartron JP. Structural analysis of a blood group-Stones active hybrid sialoglycoprotein from human red cell membranes (abstract). Biol Chem Hoppe-Seyler 1985; 366:766.Search in Google Scholar

12.Blanchard D, Piller E, Gillard B, Marcus D, Cartron JP. Identification of a novel ganglioside on erythrocytes with blood group Cad specificity. J Biol Chem 1985;260:7813–6.10.1016/S0021-9258(17)39523-6Search in Google Scholar

13.Brown PJ, Evans JP, Sinor LT, Tilzer LL, Plapp FV. The Rhesus D antigen is a dicyclohexylcarbodiimide binding proteolipid. Am J Pathol 1983;110:127–34.Search in Google Scholar

14.Cartron JP, Blanchard D. Association of human erythrocyte membrane glycoproteins with blood-group Cad specificity. Biochem J 1982;207:497–504.10.1042/bj207049711538896187337Search in Google Scholar

15.Childs RA, Feizi T, Fukuka M, et al. Blood groupSearch in Google Scholar